This inventor holds 10 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Pioneer Hi-Bred International, Inc., Vilnius University. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Vilniaus, LT (2020)
- Vilnius, LT (2022)
- Vilniaus r., LT (2017 - 2023)
- Paberze, LT (2021 - 2023)
Company Filing History:
Years Active: 2017-2026
Title: The Innovative Contributions of Tautvydas Karvelis in Genome Editing
Introduction
Tautvydas Karvelis, an accomplished inventor based in Vilnius, Lithuania, has made significant strides in the realm of genomic technology. With a total of five patents to his name, Karvelis is known for his groundbreaking work on CRISPR-Cas systems, which have revolutionized genome editing techniques. His contributions have opened new avenues for genetic research and biotechnological applications.
Latest Patents
Karvelis's latest patents focus on innovative compositions and methods for genome modification of target sequences within the genome of a cell. This work involves the use of a novel Cas endonuclease, employing a guide polynucleotide/endonuclease system that effectively modifies or alters target sequences. Notably, his patents detail the development of guide polynucleotide/endonuclease systems comprising at least one endonuclease, which can be covalently or non-covalently linked to additional protein subunits. These systems offer direct delivery methods for endonucleases as ribonucleotide proteins, enhancing the precision and efficacy of genome editing.
Career Highlights
Karvelis's career has been marked by his role at Pioneer Hi-Bred International, Inc., a leading agricultural biotechnology company. His work there underscores his commitment to advancing genetic engineering technologies, contributing not only to the company's research initiatives but also to the broader scientific community's understanding of CRISPR technology.
Collaborations
Throughout his career, Tautvydas Karvelis has collaborated with prominent figures in the field, including Virginijus Siksnys and Joshua K. Young. These partnerships have fostered a collaborative environment that has propelled advancements in genomic editing practices and methodologies. Their combined expertise has greatly enhanced the development of CRISPR-Cas systems and their practical applications in both research and industry.
Conclusion
Tautvydas Karvelis stands out as a distinguished inventor whose innovative work in genome editing through CRISPR technology signifies a pivotal step forward in genetic research. His patents and collaborations highlight his vital role in shaping the future of biotechnology. Through his endeavors, Karvelis continues to contribute to the scientific advancements that will benefit various fields, from agriculture to medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile